Metabolic Reprogramming by Hexosamine Biosynthetic and Golgi N-Glycan Branching Pathways

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Ryczko, Michael C ^a,b   Pawling, Judy ^a   Chen, Rui ^c,d   Abdel Rahman, Anas M ^a,e   Yau, Kevin ^a   Copeland, Julia K ^f   Zhang, Cunjie ^a   Surendra, Anu ^f   Guttman, David S ^f   Figeys, Daniel ^c,g   Dennis, James W ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

^d DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^e KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^f UNIVERSITY OF TORONTO   (Canada)

^g UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA-1,6-MANNOSYLGLYCOPROTEIN BETA 1,6-N-ACETYLGLUCOSAMINYLTRANSFERASE; GLUCOSAMINE; GLUCOSE; GLYCOGEN LIVER LEVEL; N ACETYLGLUCOSAMINE; N ACETYLGLUCOSAMINYLTRANSFERASE; POLYSACCHARIDE; UDP-GLUCOSAMINE;

3T3-L1 CELL LINE; AGE; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; BODY WEIGHT; C57BL MOUSE; CELL CULTURE; CELL LINE; DRUG EFFECTS; ENERGY METABOLISM; GENETICS; GLYCOGEN LIVER LEVEL; GOLGI COMPLEX; HOMEOSTASIS; INTESTINE FLORA; KNOCKOUT MOUSE; LIPID METABOLISM; LIQUID CHROMATOGRAPHY; MALE; METABOLISM; MOUSE; ORAL DRUG ADMINISTRATION; TANDEM MASS SPECTROMETRY;

3T3-L1 CELLS; ACETYLGLUCOSAMINE; ADMINISTRATION, ORAL; AGE FACTORS; ANIMALS; BIOSYNTHETIC PATHWAYS; BODY WEIGHT; CELL LINE; CELLS, CULTURED; CHROMATOGRAPHY, LIQUID; ENERGY METABOLISM; GASTROINTESTINAL MICROBIOME; GLUCOSAMINE; GLUCOSE; GOLGI APPARATUS; HOMEOSTASIS; LIPID METABOLISM; LIVER GLYCOGEN; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; N-ACETYLGLUCOSAMINYLTRANSFERASES; POLYSACCHARIDES; TANDEM MASS SPECTROMETRY;

EID: 84961859322     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep23043     Document Type: Article

References (60)

1. Banerjee, S. et al. The evolution of N-glycan-dependent endoplasmic reticulum quality control factors for glycoprotein folding and degradation. Proc Natl Acad Sci USA 104, 11676-11681 (2007).
2. Abdel Rahman, A. M., Ryczko, M., Pawling, J., Dennis, J. W. Probing the hexosamine biosynthetic pathway in human tumor cells by multitargeted tandem mass spectrometry. ACS chemical biology 8, 2053-2062 (2013).
3. Broschat, K. O. et al. Kinetic characterization of human glutamine-fructose-6-phosphate amidotransferase I: potent feedback inhibition by glucosamine 6-phosphate. J. Biol. Chem. 277, 14764-14770 (2002).
4. Veerababu, G. et al. Overexpression of glutamine: fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity and impaired glucose tolerance. Diabetes 49, 2070-2078 (2000).
5. Hardiville, S., Hart, G. W. Nutrient regulation of signaling, transcription and cell physiology by O-GlcNAcylation. Cell Metab 20, 208-213 (2014).
6. McClain, D. A. et al. Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia. Proc Natl Acad Sci USA 99, 10695-10699 (2002).
7. McClain, D. A. Hexosamines as mediators of nutrient sensing and regulation in diabetes. J. Diabetes Complicat. 16, 72-80 (2002).
8. Macauley, M. S., Shan, X., Yuzwa, S. A., Gloster, T. M., Vocadlo, D. J. Elevation of Global O-GlcNAc in rodents using a selective O-GlcNAcase inhibitor does not cause insulin resistance or perturb glucohomeostasis. Chemistry & Biology 17, 949-958 (2010).
9. Macauley, M. S. et al. Inhibition of O-GlcNAcase using a potent and cell-permeable inhibitor does not induce insulin resistance in 3T3-L1 adipocytes. Chemistry & Biology 17, 937-948 (2010).
10. Yang, Y. R. et al. Obesity resistance and increased energy expenditure by white adipose tissue browning in Oga (+/? ) mice. Diabetologia 58, 2867-2876 (2015).
11. Ghosh, S. K. et al. Disruption of O-GlcNAc Cycling in C. elegans Perturbs Nucleotide Sugar Pools and Complex Glycans. Front Endocrinol (Lausanne) 5, 197 (2014).
12. Ohtsubo, K. et al. Dietary and genetic control of glucose transporter 2 glycosylation promotes insulin secretion in suppressing diabetes. Cell 123, 1307-1321 (2005).
13. Johswich, A. et al. N-Glycan Remodeling on Glucagon Receptor Is an Effector of Nutrient Sensing by the Hexosamine Biosynthesis Pathway. J Biol Chem 289, 15927-15941 (2014).
14. Schachter, H. Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides. Biochem.Cell Biol. 64, 163-181 (1986).
15. Lau, K. S. et al. Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 129, 123-134 (2007).
16. Granovsky, M. et al. Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nature Med. 6, 306-312 (2000).
17. Demetriou, M., Granovsky, M., Quaggin, S., Dennis, J. W. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409, 733-739 (2001).
18. Soleimani, L., Roder, J. C., Dennis, J. W., Lipina, T. Beta N-acetylglucosaminyltransferase V (Mgat5) deficiency reduces the depression-like phenotype in mice. Genes Brain Behav 7, 334-343 (2008).
19. Cheung, P. et al. Metabolic homeostasis and tissue renewal are dependent on beta1,6GlcNAc-branched N-glycans. Glycobiology 17, 828-837 (2007).
20. Dennis, J. W., Nabi, I. R., Demetriou, M. Metabolism, cell surface organization, and disease. Cell 139, 1229-1241 (2009).
21. Ohtsubo, K. et al. N-Glycosylation modulates the membrane sub-domain distribution and activity of glucose transporter 2 in pancreatic beta cells. Biochem Biophys Res Commun 434, 346-351 (2013).
22. Abdel Rahman, A. M. et al. Golgi N-glycan branching N-acetylglucosaminyltransferases I, V and VI promote nutrient uptake and metabolism. Glycobiology 25, 225-240 (2015).
23. Wellen, K. E. et al. The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. Genes Dev 24, 2784-2799 (2010).
24. Lee, K. Y. et al. Subchronic toxicity study of dietary N-acetylglucosamine in F344 rats. Food Chem Toxicol 42, 687-695 (2004).
25. Takahashi, M. et al. Lack of chronic toxicity or carcinogenicity of dietary N-acetylglucosamine in F344 rats. Food Chem Toxicol 47, 462-471 (2009).
26. Salvatore, S. et al. A pilot study of N-acetyl glucosamine, a nutritional substrate for glycosaminoglycan synthesis, in paediatric chronic inflammatory bowel disease. Aliment Pharmacol Ther 14, 1567-1579 (2000).
27. Grigorian, A. et al. Control of T cell mediated autoimmunity by metabolite flux to N-glycan biosynthesis. J Biol Chem 282, 20027-20035 (2007).
28. DeWeerdt, S. Microbiome: A complicated relationship status. Nature 508, S61-63 (2014).
29. Uldry, M., Ibberson, M., Hosokawa, M., Thorens, B. GLUT2 is a high affinity glucosamine transporter. FEBS Lett 524, 199-203 (2002).
30. Wolosker, H. et al. Molecularly cloned mammalian glucosamine-6-phosphate deaminase localizes to transporting epithelium and lacks oscillin activity. FASEB J 12, 91-99 (1998).
31. Singh, R. et al. Autophagy regulates lipid metabolism. Nature 458, 1131-1135 (2009).
32. Hardie, D. G. Organismal carbohydrate and lipid homeostasis. Cold Spring Harb Perspect Biol 4 (2012).
33. Newgard, C. B. et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9, 311-326 (2009).
34. Chen, R., Seebun, D., Ye, M., Zou, H., Figeys, D. Site-specific characterization of cell membrane N-glycosylation with integrated hydrophilic interaction chromatography solid phase extraction and LC-MS/MS. Journal of proteomics 103, 194-203 (2014).
35. Nairn, A. V. et al. Regulation of glycan structures in animal tissues: transcript profiling of glycan-related genes. J Biol Chem 283, 17298-17313 (2008).
36. Mendelsohn, R. et al. Control of tumor metabolism and growth by N-glycan processing Cancer Res 67, 9771-9780 (2007).
37. Petersen, K. F. et al. Effect of aging on muscle mitochondrial substrate utilization in humans. Proc Natl Acad Sci USA 112, 11330-11334 (2015).
38. El Kaoutari, A., Armougom, F., Gordon, J. I., Raoult, D., Henrissat, B. The abundance and variety of carbohydrate-active enzymes in the human gut microbiota. Nature reviews. Microbiology 11, 497-504 (2013).
39. Zoncu, R., Efeyan, A., Sabatini, D. M. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol 12, 21-35, doi: 10.1038/nrm3025 (2011).
40. Sengupta, S., Peterson, T. R., Laplante, M., Oh, S., Sabatini, D. M. mTORC1 controls fasting-induced ketogenesis and its modulation by ageing. Nature 468, 1100-1104 (2010).
41. Unger, R. H., Clark, G. O., Scherer, P. E., Orci, L. Lipid homeostasis, lipotoxicity and the metabolic syndrome. Biochim Biophys Acta 1801, 209-214 (2010).
42. Weigert, C. et al. The-913 G/A glutamine:fructose-6-phosphate aminotransferase gene polymorphism is associated with measures of obesity and intramyocellular lipid content in nondiabetic subjects. J Clin Endocrin Metab 90, 1639-1643 (2005).
43. Liu, K. et al. Molecular characterization, chromosomal location, alternative splicing and polymorphism of porcine GFAT1 gene. Mol Biol Rep 37, 2711-2717 (2010).
44. Sage, A. T. et al. Hexosamine biosynthesis pathway flux promotes endoplasmic reticulum stress, lipid accumulation and inflammatory gene expression in hepatic cells. Am J Physiol Endocrinol Metab 298, E499-511 (2010).
45. Hsieh, T. J., Lin, T., Hsieh, P. C., Liao, M. C., Shin, S. J. Suppression of Glutamine:fructose-6-phosphate amidotransferase-1 inhibits adipogenesis in 3T3-L1 adipocytes. J Cell Physiol 227, 108-115 (2012).
46. O'Rourke, R. W. et al. Hexosamine biosynthesis is a possible mechanism underlying hypoxia's effects on lipid metabolism in human adipocytes. PLoS One 8, e71165 (2013).
47. Arakane, Y. et al. Both UDP N-acetylglucosamine pyrophosphorylases of Tribolium castaneum are critical for molting, survival and fecundity. Insect Biochem Mol Biol 41, 42-50 (2011).
48. Schwerin, M., Kuehn, C., Wimmers, S., Walz, C., Goldammer, T. Trait-associated expressed hepatic and intestine genes in cattle of different metabolic type-putative functional candidates for nutrient utilization. J Anim Breed Genet 123, 307-314 (2006).
49. Yazbek, S. N. et al. Deep congenic analysis identifies many strong, context-dependent QTLs, one of which, Slc35b4, regulates obesity and glucose homeostasis. Genome Res 21, 1065-1073 (2011).
50. Chen, J. et al. Identifying candidate genes for Type 2 Diabetes Mellitus and obesity through gene expression profiling in multiple tissues or cells. J Diabetes Res 2013, 970435 (2013).
51. Maszczak-Seneczko, D. et al. UDP-galactose (SLC35A2) and UDP-N-acetylglucosamine (SLC35A3) Transporters Form Glycosylation-related Complexes with Mannoside Acetylglucosaminyltransferases (Mgats). J Biol Chem 290, 15475-15486 (2015).
52. O'Rourke R., W. Metabolic thrift and the genetic basis of human obesity. Ann Surg 259, 642-648 (2014).
53. Kamada, Y. et al. N-Acetylglucosaminyltransferase V regulates TGF-beta response in hepatic stellate cells and the progression of steatohepatitis. Glycobiology 22, 778-787 (2012).
54. Kamada, Y. et al. Ectopic expression of N-acetylglucosaminyltransferase V accelerates hepatic triglyceride synthesis. Hepatol Res (2015).
55. Dennis, J. W., Brewer, C. F. Density-dependent lectin-glycan interactions as a paradigm for conditional regulation by posttranslational modifications. Mol Cell Proteomics 12, 913-920 (2013).
56. Shahidi, F., Abuzaytoun, R. Chitin, chitosan, and co-products: chemistry, production, applications and health effects. Advances in food and nutrition research 49, 93-135 (2005).
57. Mkhikian, H. et al. Genetics and the environment converge to dysregulate N-glycosylation in multiple sclerosis. Nat Commun 2, 334 (2011).
58. Boersema, P. J., Raijmakers, R., Lemeer, S., Mohammed, S., Heck, A. J. Multiplex peptide stable isotope dimethyl labeling for quantitative proteomics. Nat Protoc 4, 484-494 (2009).
59. Boersema, P. J., Geiger, T., Wisniewski, J. R., Mann, M. Quantification of the N-glycosylated secretome by super-SILAC during breast cancer progression and in human blood samples. Mol Cell Proteomics 12, 158-171 (2013).
60. Xia, J., Wishart, D. S. Web-based inference of biological patterns, functions and pathways from metabolomic data using MetaboAnalyst. Nat Protoc 6, 743-760 (2011).